Recursion announced that the first patient has been dosed in its Phase 1/2 clinical trial of REC-1245, a new chemical entity for the treatment of biomarker-enriched solid tumors and lymphoma.

Scaler, a tech education start-up, has announced the acquisition of a Delhi-based education platform, Pepcoding, for an undisclosed amount. This is the fourth acquisition the Tiger Global and ...